Bioperfectus Assisting Namibia in Combating COVID-19!
As Thanksgiving is approaching this year, bioPerfectus would like to express our deep gratitude to all the healthcare workers fighting against the ongoing COVID-19 crisis all the around the world. For your safety and the safety of our community, let’s stay home this Thanksgiving and enjoy a safe, happy family union.
As winter moves in, COVID-19 cases, hospitalizations and the number of deaths across the world are incredibly rising. In all its various methods, testing is and will be a mainstay for the foreseeable future. However, it is critical to choose the method of testing since the best solution may be not the same during the whole progression of COVID-19.
Bioperfectus takes the lead in developing and producing COVID-19 nucleic acid test kits
Bioperfectus Launches New Product-Novel Corona Virus (SARS-CoV-2) Ag Rapid Test Kit to Combat COVID-19 Globally
Bioperfectus Novel Corona Virus (SARS-CoV-2) IgM/IgG Rapid Test obtained EU CE certification
HIV (human immunodeficiency virus) is a virus that attacks cells that help the body fight infection, making a person more vulnerable to other infections and diseases.
Influenza and COVID-19 are different diseases caused by completely different viruses. COVID-19 is about 4-5 times as contagious as the flu. It is very important for us to distinguish between these two since it is the first step to determine a therapy solution to the diseases.
It is still a challenging thing for the northern hemisphere encountering "twindemic", a simultaneous COVID-19 and flu outbreak.
Bioperfectus Influenza Real-Time PCR reagent Kit is used to determine the presence of Influenza A or B in a patient's specimen.
